Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its flagship oncology therapy.Check out the current price of CTXR stock here. LYMPHIR Launch Marks First... Read more
Benzinga - Dec 24
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently, Vertex Pharmaceuticals has a market capitalization of $116.23 billion. Buying $100 In VRTX: If ...Full story available on... Read more
Benzinga - Dec 05
The United States and the United Kingdom have agreed on a zero-tariffs deal for medications manufactured in Britain. The NHS will pay more for drugs. Read more
Upi - Dec 01
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.96% on an annualized basis producing an average annual return of 23.64%. Currently, Regeneron Pharmaceuticals has a market capitalization of $79.69 billion. Buying $1000 In REGN: If ...Full story avai... Read more
Benzinga - Nov 24
Shuttle Pharmaceuticals Holdings Inc. (NASDAQ:SHPH) rose 27.87% in after-hours trading on Thursday, reaching $2.34.Check out the current price of SHPH stock here.The stock of the biotech closed Thursday's regular session down 7.58% at $1.83, according to Benzinga Pro data.S-1 Registration Stateme... Read more
Benzinga - Nov 21
Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX – Get Free Report)’s share price dropped 0.4% on Monday . The company traded as low as $5.29 and last traded at $5.46. Approximately 9,959 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 164,00... Read more
Americanbankingnews - Nov 18
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) and Zimmer Biomet (NYSE:ZBH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earning... Read more
Ticker Report - Nov 17
Zimmer Biomet (NYSE:ZBH – Get Free Report) and Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownershi... Read more
Watch List News - Nov 17
Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive local... Read more
Benzinga - Nov 17
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $10.34, but opened at $9.00. Day One Biopharmaceuticals shares last traded at $9.9350, with a volume of 902,966 shares. Wall Street ... Read more
Markets Daily - Nov 15
